x |
| Latest 12 months Revenue for Acorda Therapeutics is Up 13.13% according to T12-NEWS |
|
Stock Quote: (NasdaqNM:ACOR) |
| 11/11/2009 |
|
| 26.41 |
 -0.03 |
-0.11% |
356,066 |
|
| Latest 12 months Revenue for Acorda Therapeutics is Up 13.13% according to T12-NEWS |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, NY, November 11, 2009,T12-NEWS says that trailing twelve month (TTM) Revenue for Acorda Therapeutics (NASDAQ:ACOR) for its twelve months ended September 30, 2009 increased by 13.13% to $52,6 ... read full story |
|
|
|
